Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (71-80 of 261) with videos related to

Pageof 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in childrenIain Stephenson, Jane Democratis, Angie Lackenby, et al.
International Journal of Epidemiology|May 4, 2021
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative designJulia Stowe, Elise Tessier, H Zhao, et al.
Influenza and Other Respiratory Viruses|January 3, 2013
Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemicCharles R Beck, Rachel Sokal, Nachiappan Arunachalam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
The mechanism of resistance to favipiravir in influenzaDaniel H Goldhill, Aartjan J W Te Velthuis, Robert A Fletcher, et al.
Journal of Virology|November 2, 2018
Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation SequencingDaniel H Goldhill, Pinky Langat, Hongyao Xie, et al.
Emerging Infectious Diseases|October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of General Virology|November 22, 2005
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid proteinJaehwan You, Brian K Dove, Luis Enjuanes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 6, 2020
Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?Elizabeth M Dickson, Maria Zambon, Richard Pebody, et al.
Vaccine|February 20, 2020
Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIVKatja Hoschler, Sunil Maharjan, Heather Whitaker, et al.
Vaccine|June 3, 2008
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvantsKatarina Radosević, Ariane Rodriguez, Ratna Mintardjo, et al.
Pageof 27

Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in childrenIain Stephenson, Jane Democratis, Angie Lackenby, et al.
International Journal of Epidemiology|May 4, 2021
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative designJulia Stowe, Elise Tessier, H Zhao, et al.
Influenza and Other Respiratory Viruses|January 3, 2013
Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemicCharles R Beck, Rachel Sokal, Nachiappan Arunachalam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
The mechanism of resistance to favipiravir in influenzaDaniel H Goldhill, Aartjan J W Te Velthuis, Robert A Fletcher, et al.
Journal of Virology|November 2, 2018
Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation SequencingDaniel H Goldhill, Pinky Langat, Hongyao Xie, et al.
Emerging Infectious Diseases|October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of General Virology|November 22, 2005
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid proteinJaehwan You, Brian K Dove, Luis Enjuanes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 6, 2020
Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?Elizabeth M Dickson, Maria Zambon, Richard Pebody, et al.
Vaccine|February 20, 2020
Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIVKatja Hoschler, Sunil Maharjan, Heather Whitaker, et al.
Vaccine|June 3, 2008
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvantsKatarina Radosević, Ariane Rodriguez, Ratna Mintardjo, et al.
Pageof 27